Lipocine Inc. Annual Income Tax Expense (Benefit) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Lipocine Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2023.
  • Lipocine Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $481.000.
  • Lipocine Inc. annual Income Tax Expense (Benefit) for 2023 was $755.000, a 10.9% increase from 2022.
  • Lipocine Inc. annual Income Tax Expense (Benefit) for 2022 was $681.000, a 241% increase from 2021.
  • Lipocine Inc. annual Income Tax Expense (Benefit) for 2021 was $200.000, unchanged from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $755 +$74.00 +10.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $681 +$481 +241% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $200 $0 0% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $200 $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $200 -$500 -71.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $700 $0 0% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $700 -$52 -6.92% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 $752 +$552 +276% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
2015 $200 $0 0% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $200 +$55.2K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 -$55K -$55.7K -8148% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-11
2012 $684 Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.